Age-and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients

British Journal of Cancer

Volumn 105, Issue 3, 2011, Pages 445-451

  Singer, S ^a,b   Kuhnt, S ^b   Zwerenz, R ^c   Eckert, K ^b   Hofmeister, D ^b   Dietz, A ^b   Giesinger, J ^d   Hauss, J ^b   Papsdorf, K ^b   Briest, S ^b   Brown, A ^e  

^a UNIVERSITY OF WUPPERTAL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER FATIGUE; CANCER PATIENT; CANCER STAGING; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; FEMALE; FOLLOW UP; GROUPS BY AGE AND SEX; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL FATIGUE INVENTORY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SEX DIFFERENCE; TREND STUDY; TUMOR LOCALIZATION;

ADULT; AGE FACTORS; FATIGUE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 79960840214     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.251     Document Type: Article

References (29)

1. Agasi-Idenburg C, Velthuis M, Wittink H (2010) Quality criteria and user-friendliness in self-reported questionnaires on cancer-related fatigue: a review. J Clin Epidemiol 63: 705-711
2. Andrykowski MA, Jacobsen P (2010) Prevalence, predictors, and trajectory of cancer-related fatigue in breast cancer (Bc) survivors. Ann Behav Med 39: 50
3. Barsevick A, Beck SL, Dudley WN, Wong B, Berger AM, Whitmer K, Newhall T, Brown S, Stewart K (2010) Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage 40: 200-216
4. Brix C, Schleussner C, Fuller J, Rohrig B, Strauss B (2009) Fatigue and its determinants in radio-oncology. Psychother Psychosom Med Psychol 59: 42-49
5. Bruera E, Yennurajalingam S (2010) Challenge of managing cancer-related fatigue. J Clin Oncol 28: 3671-3672
6. Cella D, Davis K, Breitbart W, Curt G, for the Fatigue Coalition (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a united states sample of cancer survivors. J Clin Oncol 19: 3385-3391 (Pubitemid 32642191)
7. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ(2000) Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist 5: 353-360
8. Fayers P (2001) Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 37: 1331-1334 (Pubitemid 32588741)
9. Goedendorp MM, Gielissen MFM, Verhagen CAH, Peters MEJW, Bleijenberg G (2008) Severe fatigue and related factors in cancer patients before the initiation of treatment. Br J Cancer 99: 1408-1414
10. Hagelin CL, Wengstrom Y, Furst CJ (2009) Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer-a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer 17: 519-526
11. Heutte N, Flechtner HH, Mounier N, Mellink WAM, Meerwaldt JH, Eghbali H, van't Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RWM, Smit WGJM, Brice P, Kooy MV, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomsic R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers GJM, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Ferme C, Henry-Amar M (2009) Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10: 1160-1170
12. Holzner B, Kemmler G, Greil R, Kopp M, Zeimet A, Raderer M, Hejna M, Zochbauer S, Krajnik G, Huber H, Fleischhacker WW, Sperner-Unterweger B (2002) The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol 13: 965-973 (Pubitemid 34752693)
13. Holzner B, Kemmler G, Meraner V, Maislinger A, Kopp M, Bodner T, Nguyen-Van-Tam D, Zeimet AG, Fleischhacker WW, Sperner-Unterwe-ger B (2003) Fatigue in ovarian carcinoma patients-a neglected issue? Cancer 97: 1564-1572 (Pubitemid 36297787)
14. Houborg KB, Jensen MB, Rasmussen P, Gandrup P, Schroll M, Laurberg S (2006) Postoperative physical training following colorectal surgery. A randomised, placebo-controlled study. Scand J Surg 95: 17-22
15. Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, Peppone L, Hemstad A, Esparaz BT, Hopkins JO (2010) A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy. Cancer 116: 3513-3520
16. Kuhnt S, Ernst J, Singer S, Ruffer JU, Kortmann RD, Stolzenburg JU, Schwarz R (2009) Fatigue in cancer survivors-prevalence and correlates. Onkologie 32: 312-317
17. Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fossa SD (2010) Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis 13: 144-150
18. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu ZN, Manning D (2009) Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage 38: 650-662
19. Meek P, Nail L, Barsevick A, Schwartz A, Stephen S, Whitmer K, Beck SL, Jones L, Walker B (2000) Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res 49: 181-190
20. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, Suh JJ, Griffin PC, Johnson DB, Ali A, Silberstein PT, Duane SF, Loprinzi CL (2010) Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: north central cancer treatment group NCCTG-N05C7 trial. J Clin Oncol 28: 3673-3679
21. Prue G, Allen J, Gracey J, Rankin J, Cramp F (2010) Fatigue in gynecological cancer patients during and after anticancer treatment. J Pain Symptom Manage 39: 197-210
22. Purcell A, Fleming J, Bennett S, Burmeister B, Haines T (2010) Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer 18: 307-315
23. Riesenberg H, Lubbe AS (2010) In-patient rehabilitation of lung cancer patients-a prospective study. Support Care Cancer 18: 877-882
24. Schwarz R, Krauß O, Hinz A (2003) Fatigue in the general population. Onkologie 26: 140-144 (Pubitemid 36677078)
25. Smets EM, Garssen B, Bonke B, de Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39: 315-325
26. Smets EM, Garssen B, Cull A, de Haes JC (1996) Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 73: 241-245 (Pubitemid 26028340)
27. StataCorp (2009) Stata Statistical Software: Release 11. StataCorp LP, College Station, TX
28. Teunissen SCCM, Wesker W, Kruitwagen C, De Haes HCJM, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34: 94-104 (Pubitemid 46970881)
29. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: result of a tripart assessment survey. Semin Hematol 34: 4-12 (Pubitemid 27319139)